Cite
HARVARD Citation
Derikx, L. et al. (n.d.). P579 Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohns's disease. Journal of Crohn's and colitis. pp. i519-i520. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Derikx, L. et al. (n.d.). P579 Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohns's disease. Journal of Crohn's and colitis. pp. i519-i520. [Online].